Graf James A
- SEC CIK
- 0001519672
No open-market purchases or sales filed in the past year.
Current role at each company
- TONT Graf Global Corp.CEO and CFOas of Jun 22, 2026
- NKGN NKGen Biotech, Inc.Interim CFOas of Dec 26, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Graf James A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NKGN NKGen Biotech, Inc.
Interim CFO2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2023 (view filing)3:50 PM ET | Dec 1-4 | 4 days | Graf James A and 1 otherInterim CFO | PPurchase | +670 | $3.24 | +$2.17K | +2,913.0%693 after | 2 lots |
| Nov 22, 2023 (view filing)5:55 PM ET | Nov 20-21 | 2 days | Graf James A and 1 otherInterim CFO | PPurchase | +23 | $2.93 | +$67.3 | New position23 after | 2 lots |